Literature DB >> 13678417

Glucose 6-phosphate causes translocation of phosphorylase in hepatocytes and inactivates the enzyme synergistically with glucose.

Susan Aiston1, Andrew Green, Mohammed Mukhtar, Loranne Agius.   

Abstract

The role of glucose 6-P (glucose 6-phosphate) in regulating the activation state of glycogen synthase and its translocation is well documented. In the present study, we investigated the effects of glucose 6-P on the activation state and compartmentation of phosphorylase in hepatocytes. Glucose 6-P levels were modulated in hepatocytes by glucokinase overexpression or inhibition with 5-thioglucose and the effects of AMP were tested using AICAR (5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside), which is metabolized to an AMP analogue. Inhibition of glucokinase partially counteracted the effect of glucose both on the inactivation of phosphorylase and on the translocation of phosphorylase a from a soluble to a particulate fraction. The increase in glucose 6-P caused by glucokinase overexpression caused translocation of phosphorylase a to the pellet and had additive effects with glucose on inactivation of phosphorylase. It decreased the glucose concentration that caused half-maximal inactivation from 20 to 11 mM, indicating that it acts synergistically with glucose. AICAR activated phosphorylase and counteracted the effect of glucose 6-P on phosphorylase inactivation. However, it did not counteract translocation of phosphorylase by glucose 6-P. Glucose 6-P and AICAR had opposite effects on the activation state of glycogen synthase, but they had additive effects on translocation of the enzyme to the pellet. There was a direct correlation between the translocation of phosphorylase a and of glycogen synthase to the pellet, suggesting that these enzymes translocate in tandem. In conclusion, glucose 6-P causes both translocation of phosphorylase and inactivation, indicating a more complex role in the regulation of glycogen metabolism than can be explained from regulation of glycogen synthase alone.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 13678417      PMCID: PMC1223839          DOI: 10.1042/BJ20031191

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  Hepatic glycogen synthesis is highly sensitive to phosphorylase activity: evidence from metabolic control analysis.

Authors:  S Aiston; L Hampson; A M Gómez-Foix; J J Guinovart; L Agius
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

2.  5-Aminoimidazole-4-carboxamide 1-beta -D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms.

Authors:  Sarah L Longnus; Richard B Wambolt; Hannah L Parsons; Roger W Brownsey; Michael F Allard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-04       Impact factor: 3.619

3.  Probable formation of partially phosphorylated intermediates in the interconversions of phosphorylase A and B.

Authors:  S S Hurd; D Teller; E H Fischer
Journal:  Biochem Biophys Res Commun       Date:  1966-07-06       Impact factor: 3.575

4.  Investigation of the mechanism by which glucose analogues cause translocation of glucokinase in hepatocytes: evidence for two glucose binding sites.

Authors:  L Agius; M Stubbs
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

Review 5.  Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1.

Authors:  C B Newgard; M J Brady; R M O'Doherty; A R Saltiel
Journal:  Diabetes       Date:  2000-12       Impact factor: 9.461

6.  Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes.

Authors:  Meredith Hawkins; Ilan Gabriely; Robert Wozniak; Cristian Vilcu; Harry Shamoon; Luciano Rossetti
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

7.  Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2.

Authors:  Karim El-Haschimi; Scott D Dufresne; Michael F Hirshman; Jeffrey S Flier; Laurie J Goodyear; Christian Bjørbaek
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

8.  Glucose 6-phosphate produced by gluconeogenesis and by glucokinase is equally effective in activating hepatic glycogen synthase.

Authors:  Roger R Gomis; Cristián Favre; Mar García-Rocha; Josep M Fernández-Novell; Juan C Ferrer; Joan J Guinovart
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

9.  Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes.

Authors:  Theodore Latsis; Birgitte Andersen; Loranne Agius
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

10.  Regulation of glycogen synthase by glucose and glycogen: a possible role for AMP-activated protein kinase.

Authors:  Reza Halse; Lee G D Fryer; James G McCormack; David Carling; Stephen J Yeaman
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

View more
  8 in total

Review 1.  Hepatic glucose sensing and integrative pathways in the liver.

Authors:  Maaike H Oosterveer; Kristina Schoonjans
Journal:  Cell Mol Life Sci       Date:  2013-11-07       Impact factor: 9.261

2.  Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs.

Authors:  Tracy P Torres; Noriyasu Sasaki; E Patrick Donahue; Brooks Lacy; Richard L Printz; Alan D Cherrington; Judith L Treadway; Masakazu Shiota
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

3.  Differential regulation of glycogenolysis by mutant protein phosphatase-1 glycogen-targeting subunits.

Authors:  Arpad M Danos; Senad Osmanovic; Matthew J Brady
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

4.  Postprandial Glycogen Content Is Increased in the Hepatocytes of Human and Rat Cirrhotic Liver.

Authors:  Natalia N Bezborodkina; Sergey V Okovityi; Boris N Kudryavtsev
Journal:  Cells       Date:  2021-04-21       Impact factor: 6.600

5.  Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes.

Authors:  Michaela Kacerovsky; John Jones; Albrecht I Schmid; Cristina Barosa; Angelika Lettner; Gertrud Kacerovsky-Bielesz; Julia Szendroedi; Marek Chmelik; Peter Nowotny; Visvanathan Chandramouli; Michael Wolzt; Michael Roden
Journal:  Diabetes       Date:  2011-05-11       Impact factor: 9.461

6.  Glycogen synthesis correlates with androgen-dependent growth arrest in prostate cancer.

Authors:  Joachim B Schnier; Kayoko Nishi; Paul H Gumerlock; Frederic A Gorin; E Morton Bradbury
Journal:  BMC Urol       Date:  2005-03-24       Impact factor: 2.264

7.  Liver glycogen loading dampens glycogen synthesis seen in response to either hyperinsulinemia or intraportal glucose infusion.

Authors:  Jason J Winnick; Zhibo An; Guillaume Kraft; Christopher J Ramnanan; Jose M Irimia; Marta Smith; Margaret Lautz; Peter J Roach; Alan D Cherrington
Journal:  Diabetes       Date:  2012-08-24       Impact factor: 9.461

8.  Glycogen phosphorylase inhibitor N-(3,5-dimethyl-Benzoyl)-N'-(β-D-glucopyranosyl)urea improves glucose tolerance under normoglycemic and diabetic conditions and rearranges hepatic metabolism.

Authors:  Lilla Nagy; Tibor Docsa; Magdolna Szántó; Attila Brunyánszki; Csaba Hegedűs; Judit Márton; Bálint Kónya; László Virág; László Somsák; Pál Gergely; Péter Bai
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.